Patent 9192616 was granted and assigned to Salix Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.
A method of increasing the bioavailability of balsalazide by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of balsalazide in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.